GTS Securities’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-37,500
Closed -$8.27M 1797
2024
Q3
$8.27M Buy
37,500
+18,200
+94% +$3.77M 0.02% 594
2024
Q2
$3.79M Sell
19,300
-3,300
-15% -$682K 0.01% 1043
2024
Q1
$4.87M Buy
22,600
+1,200
+6% +$252K 0.01% 876
2023
Q4
$4.51M Sell
21,400
-14,400
-40% -$3.07M 0.01% 1077
2023
Q3
$7.17M Buy
+35,800
New +$7.12M 0.01% 754

Other funds holding CME

GTS Securities's CME Position: Q2 2026 in Review

GTS Securities sold out of CME Group (CME) in Q2 2026, closing a stake of 2,754 shares — an estimated $813K sold.

GTS Securities first reported a position in CME in Q2 2023 and held it in 12 quarters. The position peaked at $2.92M in Q4 2023. 1,707 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • GTS Securities reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
  • GTS Securities sold 2,754 CME Group shares in Q2 2026, an estimated $813K.
  • GTS Securities first reported a position in CME Group in Q2 2023 and held it in 12 quarters.
  • GTS Securities's CME Group position peaked at $2.92M in Q4 2023.
  • 1,707 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.